\-\ Texto\\:\\ \ \(0\)\
\-\ papilledema\\ with\\ afferent\\ pupillary\\ defect\\ in\\ the\\ right\\ eye\ \(0\)\
\-\ steriods\ \(3\)\
\-\ swelling\\ and\\ asymmetry\\ of\\ the\\ optic\\ nerves\\ with\\ enhancement\\ of\\ the\\ right\\ optic\\ nerve\ \(0\)\
\-\ optic\\ neuritis\ \(15\)\
\-\ essentially\\ none\\,\\ but\\ may\\ include\\ optic\\ nerve\\ glioma\ \(0\)\
\-\ 30\\ y\\/o\\ woman\\ with\\ acute\\ onset\\ of\\ pain\\ and\\ vision\\ loss\\ in\\ the\\ right\\ eye\\.\ \(1\)\
\-\ patient\\ also\\ eventually\\ developed\\ demyelinating\\ lesions\\ in\\ the\\ anterior\\ corpus\\ callosum\\ consistent\\ with\\ multiple\\ sclerosis\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ optic\\:\\ 0\\.23616155340924333\ \(0\)\
\-\ steriods\\:\\ 0\\.1075534404706328\ \(0\)\
\-\ eye\\:\\ 0\\.10699730767498243\ \(0\)\
\-\ afferent\\:\\ 0\\.10253146678971918\ \(0\)\
\-\ pupillary\\:\\ 0\\.09448674289818652\ \(0\)\
\-\ nerve\\:\\ 0\\.091908839596636\ \(0\)\
\-\ neuritis\\:\\ 0\\.08081076182543795\ \(0\)\
\-\ asymmetry\\:\\ 0\\.07984750031592196\ \(0\)\
\-\ papilledema\\:\\ 0\\.07938822182835847\ \(0\)\
\-\ demyelinating\\:\\ 0\\.07894265521418413\ \(0\)\
\-\ essentially\\:\\ 0\\.07149502586912461\ \(0\)\
\-\ eventually\\:\\ 0\\.0702185755193013\ \(0\)\
\-\ callosum\\:\\ 0\\.06544330783765946\ \(0\)\
\-\ nerves\\:\\ 0\\.06474897924609391\ \(0\)\
\-\ corpus\\:\\ 0\\.06284101847728965\ \(0\)\
\-\ vision\\:\\ 0\\.05892513393299874\ \(0\)\
\-\ glioma\\:\\ 0\\.05750259393591926\ \(0\)\
\-\ developed\\:\\ 0\\.04910545499753305\ \(0\)\
\-\ 30\\:\\ 0\\.04904610949932948\ \(0\)\
\-\ defect\\:\\ 0\\.047742497407461594\ \(0\)\
\-\ sclerosis\\:\\ 0\\.045810675125766344\ \(0\)\
\-\ swelling\\:\\ 0\\.0424897143877781\ \(0\)\
\-\ right\\:\\ 0\\.04037156906464552\ \(0\)\
\-\ onset\\:\\ 0\\.040260018297390295\ \(0\)\
\-\ loss\\:\\ 0\\.03702185332042447\ \(0\)\
\-\ include\\:\\ 0\\.03577841026910876\ \(0\)\
\-\ y\\/o\\:\\ 0\\.03532282134059165\ \(0\)\
\-\ enhancement\\:\\ 0\\.03418639949437367\ \(0\)\
\-\ lesions\\:\\ 0\\.034142694124536535\ \(0\)\
\-\ anterior\\:\\ 0\\.03284765408601101\ \(0\)\
\-\ none\\:\\ 0\\.031637604580716516\ \(0\)\
\-\ acute\\:\\ 0\\.031490736255320825\ \(0\)\
\-\ consistent\\:\\ 0\\.03127310849001796\ \(0\)\
\-\ woman\\:\\ 0\\.02946123802222248\ \(0\)\
\-\ may\\:\\ 0\\.02797505028206155\ \(0\)\
\-\ but\\:\\ 0\\.02720154180647071\ \(0\)\
\-\ multiple\\:\\ 0\\.02686277617133237\ \(0\)\
\-\ also\\:\\ 0\\.02514357602492763\ \(0\)\
\-\ in\\:\\ 0\\.018868532692847235\ \(0\)\
\-\ pain\\:\\ 0\\.015576241306428876\ \(0\)\
\-\ patient\\:\\ 0\\.01278495419278191\ \(0\)\
\-\ the\\:\\ 0\\.010317110798778043\ \(0\)\
\-\ with\\:\\ 0\\.006985323945665059\ \(0\)\
\-\ and\\:\\ 0\\.005373403156185626\ \(0\)\
\-\ of\\:\\ 0\\.005216588095432318\ \(0\)\
\-\ \\,\\:\\ 0\\.004040448739063991\ \(0\)\
\-\ \\.\\:\\ 0\\.0010596876446969036\ \(0\)\
